- Home
- RDHL vs DCX Comparison
RDHL vs DCX Comparison
Compare RDHL & DCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RDHL | DCX |
|---|---|---|
| Founded | 2009 | 2009 |
| Country | Israel | China |
| Employees | N/A | 1389 |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6M | 3.9M |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | RDHL | DCX |
|---|---|---|
| Price | $0.81 | $1.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 21.5K | ★ 23.7K |
| Earning Date | 11-28-2025 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $381.91 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.78 | $0.34 |
| 52 Week High | $3.31 | $5.68 |
Technical Indicators
Market Signals| Indicator | RDHL | DCX |
|---|---|---|
| Relative Strength Index (RSI) | 35.82 | 45.95 |
| Support Level | $0.80 | $0.35 |
| Resistance Level | $1.07 | $2.18 |
| Average True Range (ATR) | 0.05 | 0.22 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 19.01 | 31.53 |
Price Performance
Historical ComparisonAbout RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About DCX Digital Currency X Technology Inc. Class A Ordinary Shares
Digital Currency X Technology Inc, formerly Chijet Motor Company Inc is engaged in the development, manufacture, sales, and service of new energy vehicles (NEV), hybrid vehicles and traditional fuel vehicles in China. New energy vehicles refer to plug-in electric vehicles, including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans. The company generates all of its revenue from PRC.